Metric Finance
LearnFAQ
LearnFAQ

Learn / COLL

NASDAQ: COLL

Collegium Pharmaceutical (COLL) stock, explained like you're 5

Collegium Pharmaceutical trades on the Nasdaq under the ticker COLL. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 719 million dollars.

Ticker
COLL
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 719 million dollars

Is Collegium Pharmaceutical a small, medium or large cap company?

No. Collegium Pharmaceutical is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 719 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Collegium Pharmaceutical makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves COLL stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Collegium Pharmaceutical, Inc. (COLL) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • Collegium Pharmaceutical: Under 3x Cash Earnings After A Narrow Guidance Cut (NASDAQ:COLL) (Seeking Alpha)
  • Zacks upgrades Collegium Pharmaceutical stock to strong buy (ad-hoc-news.de)
  • Four investors report shared voting power over Collegium Pharma (COLL) shares. (Stock Titan)
  • Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts (Yahoo Finance)

Follow COLL in your daily brief

Each trading day at 5 PM ET we post what happened to Collegium Pharmaceutical and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow COLL

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Collegium Pharmaceutical stock

What does Collegium Pharmaceutical do?

Collegium Pharmaceutical trades on the Nasdaq under the ticker COLL. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 719 million dollars.

What is the ticker symbol for Collegium Pharmaceutical?

Collegium Pharmaceutical trades under the ticker COLL on the Nasdaq.

What is Collegium Pharmaceutical's market cap?

Collegium Pharmaceutical is a small cap stock with a market cap of about 719 million dollars.

How does Collegium Pharmaceutical make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves COLL stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow COLL stock every day?

Add COLL to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow COLL daily

A free brief on Collegium Pharmaceutical and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare COLL: COLL vs NVS, COLL vs AZN, COLL vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed